Study examines metabolic reprogramming of breast cancer tumors during neoadjuvant chemotherapy

Study examines metabolic reprogramming of breast cancer tumors during neoadjuvant chemotherapy

In a study published in Nature Communications, scientists have made significant strides in understanding the complex interplay between the immune system and cancer metabolism in breast cancer treatment. The research offers new insights into how the immune state and cancer metabolism evolve during neoadjuvant chemotherapy (NAC).

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *